Latest return on equity
Lipocine Return on equity
Lipocine (LPCN) return on equity with its verified observation date.
Direct answer
Lipocine's return on equity is -60.94%.
The verified market snapshot reports -60.94%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 28, 2026.
Get free Lipocine email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -60.94%